Company: RNAC
Filing Date: 2025-01-08
Form Type: 424B3
Source: 0001140361-25-000626
Chunk: 5

Company: Cartesian Therapeutics, Inc.
Filing Date: 2025-01-08
Form: 424B3
Chunk 5
---
 to continue to grow our manufacturing capabilities and resources; |

2

TABLE OF CONTENTS

| • | our ability to manufacture our product candidates, which in some cases are manufactured on a patient-by-patient basis; |

| • | our ability to access manufacturing facilities and to receive or manufacture sufficient quantities of our product candidates; |

| • | our ability to maintain our existing or future collaborations or licenses and to seek new collaborations, licenses or partnerships; |

| • | the impact of resurgence of the COVID-19 pandemic on our operations, the continuity of our business, including our preclinical studies and clinical trials, and general economic conditions; |

| • | our ability to protect and enforce our intellectual property rights; |

| • | federal, state, and foreign regulatory requirements, including U.S. Food and Drug Administration, or FDA, regulation of our product candidates; |

| • | our ability to obtain and retain key executives and retain qualified personnel; and |

| • | developments relating to our competitors and our industry, including the impact of government regulation. |

The foregoing list may not contain all of the forward-looking statements made in this prospectus. These forward-looking statements are only predictions based on our current expectations and projections about future events and are subject to a number of risks, uncertainties and assumptions, including those described in “ Risk Factors” and elsewhere in this prospectus. Moreover, we operate in a competitive industry, and new risks emerge from time to time. It is not possible for the management of Cartesian to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. In light of these risks, uncertainties and assumptions, the forward-looking events and circumstances discussed in this prospectus may not occur, and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements in this prospectus. The forward-looking statements included in this prospectus are made only as of the date hereof. You should not rely upon forward-looking statements as predictions of future events. Although we believe that the expectations reflected in our forward-looking statements are reasonable, we cannot guarantee that the future results, levels of activity, performance or events and circumstances reflected in the forward-looking statements will be achieved or occur. We do not undertake any obligation to update publicly any forward-looking statements for any reason after the date of this prospectus to conform these statements to actual results or to changes in expectations